Related references
Note: Only part of the references are listed.Part-time cancers and role of melatonin in determining their metabolic phenotype
Russel J. Reiter et al.
LIFE SCIENCES (2021)
Melatonin: A promising agent targeting leukemia
Rana Shafabakhsh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Melatonin modulates proliferation of pancreatic stellate cells through caspase-3 activation and changes in cyclin A and D expression
Matias Estaras et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2020)
Melatonin modulates red-ox state and decreases viability of rat pancreatic stellate cells
Antonio Gonzalez et al.
SCIENTIFIC REPORTS (2020)
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process
Alicia Gonzalez-Gonzalez et al.
SCIENTIFIC REPORTS (2020)
A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment
Luiz Gustavo de Almeida Chuffa et al.
JOURNAL OF PINEAL RESEARCH (2020)
Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway
Gamal H. El-Sokkary et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Melatonin induces reactive oxygen species generation and changes in glutathione levels and reduces viability in human pancreatic stellate cells
Matias Estaras et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Melatonin and non-small cell lung cancer: new insights into signaling pathways
Mohammad Hossein Pourhanifeh et al.
CANCER CELL INTERNATIONAL (2019)
Ameliorative effects of melatonin against solid Ehrlich carcinoma progression in female mice
Ali H. Amin et al.
JOURNAL OF PINEAL RESEARCH (2019)
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Keywan Mortezaee et al.
LIFE SCIENCES (2019)
Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
Lingyun Zhang et al.
CELLS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Melatonin and its anti-glioma functions: a comprehensive review
Sayantan Maitra et al.
REVIEWS IN THE NEUROSCIENCES (2019)
Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy
Christopher C. Mills et al.
CANCER RESEARCH (2018)
Melatonin and Cancer Hallmarks
Wamidh H. Talib
MOLECULES (2018)
NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death
Avishai Shemesh et al.
FRONTIERS IN IMMUNOLOGY (2018)
Effect o KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion
Hong-Hao Li et al.
ONCOTARGETS AND THERAPY (2018)
The role of CD133 in cancer: a concise review
Paige M. Glumac et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Melatonin, an inhibitory agent in breast cancer
Elaheh Nooshinfar et al.
BREAST CANCER (2017)
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
Yohan Ricci Zonta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma
Shibo Lin et al.
JOURNAL OF PINEAL RESEARCH (2017)
Ki-67 Contributes to Normal Cell Cycle Progression and Inactive X Heterochromatin in p21 Checkpoint-Proficient Human Cells
Xiaoming Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Nasser Hashemi Goradel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
Kai Liu et al.
Scientific Reports (2017)
Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms
Luiz Gustavo de Almeida Chuffa et al.
CARCINOGENESIS (2017)
Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells
Junyi Gu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo
H. Wang et al.
CELL DEATH & DISEASE (2016)
Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells
Jucimara Colombo et al.
ONCOLOGY LETTERS (2016)
Melatonin downregulates nuclear receptor RZR/ROR. expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo
Ri-Xiong Wang et al.
ONCOLOGY LETTERS (2016)
Molecular Pathogenesis of Hepatocellular Carcinoma
Daniel Wai-Hung Ho et al.
LIVER CANCER (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Antioxidant Properties of Melatonin and its Potential Action in Diseases
Cigdem Karaaslan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Melatonin, its Metabolites and its Synthetic Analogs as Multi-Faceted Compounds: Antioxidant, Prooxidant and Inhibitor of Bioactivation Reactions
Hande Gurer-Orhan et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Effect of shikonin on multidrug resistance in HepG2: The role of SIRT1
Yong-Dong Jin et al.
PHARMACEUTICAL BIOLOGY (2015)
Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Naiane do Nascimento Goncalves et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma
Jinah Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells
Raquel Ordonez et al.
JOURNAL OF PINEAL RESEARCH (2014)
Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells
Sara Proietti et al.
JOURNAL OF PINEAL RESEARCH (2014)
Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling
Rita Paroni et al.
JOURNAL OF PINEAL RESEARCH (2014)
Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review)
Antonio Cutando et al.
ONCOLOGY LETTERS (2014)
Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats
Grazielle M. Ferreira et al.
JOURNAL OF CANCER (2014)
Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions
Kangsadarn Bennukul et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901
S. Zhang et al.
BIOTECHNIC & HISTOCHEMISTRY (2013)
CD133 silencing inhibits sternness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stern cells
Xi Lan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells
Virginia Alvarez-Garcia et al.
JOURNAL OF PINEAL RESEARCH (2013)
Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
Aida Rodriguez-Garcia et al.
JOURNAL OF PINEAL RESEARCH (2013)
Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting Survivin and XIAP
Lulu Fan et al.
JOURNAL OF PINEAL RESEARCH (2013)
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
H. H. J. Gerets et al.
CELL BIOLOGY AND TOXICOLOGY (2012)
Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines
Marina Sanchez-Hidalgo et al.
JOURNAL OF PINEAL RESEARCH (2012)
Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells
Abdulhadi C. Uguz et al.
JOURNAL OF PINEAL RESEARCH (2012)
The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
M. A. Bareschino et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology
Antonio Gonzalez et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor
Sara Carbajo-Pescador et al.
JOURNAL OF PINEAL RESEARCH (2011)
Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
Sung-Suk Chae et al.
CLINICAL CANCER RESEARCH (2010)
Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia
Shi-Young Park et al.
JOURNAL OF PINEAL RESEARCH (2010)
Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line
Javier Martin-Renedo et al.
JOURNAL OF PINEAL RESEARCH (2008)
Melatonin modulates the expression of VEGF and HIF-1α induced by CoCl2 in cultured cancer cells
Min Dai et al.
JOURNAL OF PINEAL RESEARCH (2008)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2
RA Osseni et al.
LIFE SCIENCES (2000)
Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells
MA El-Missiry et al.
CANCER LETTERS (2000)
Share Paper
